Targeting Nutrient Uptake Mechanisms in Plasmodium

Date

2007

Authors

Kirk, Kiaran
Saliba, Kevin

Journal Title

Journal ISSN

Volume Title

Publisher

Bentham Science Publishers Ltd

Abstract

The proliferation of the intraerythrocytic malaria parasite is dependent on the uptake from the blood plasma, and from the cytoplasm of the host cell, of a range of essential nutrients. These compounds are taken up into the parasitised cell via a combination of constitutively active endogenous host cell transporters and new parasite-induced permeability pathways. On entering the infected cell they are taken up by the intracellular parasite, across the parasitophorous vacuole and parasite plasma membranes, via a combination of channels and transporters, and/or via endocytosis. Once inside the parasite, nutrients are typically phosphorylated and thereby effectively trapped within the cell. The intraerythrocytic parasite has a range of subcellular membrane-bound organelles, each endowed with their own complement of transport proteins which mediate the uptake and efflux of metabolic substrates and byproducts. Proteins that mediate the uptake, intracellular trafficking and metabolism of essential nutrients in the Plasmodium-infected erythrocyte are potential antimalarial drug targets. Here we consider the nature of the pathways involved, focusing in particular on those that mediate the uptake of three important nutrients: glucose, the key energy-substrate for the parasite; pantothenate (vitamin B5), the precursor of the important enzyme cofactor, coenzyme A; and choline, the precursor of the phospholipid phosphatidylcholine.

Description

Keywords

amidine; ammonium derivative; antimalarial agent; carrier protein; chloroquine; choline; choline derivative; cj 15801; coenzyme A; dexpanthenol; glucose; glucose transport inhibitor; ion channel; membrane protein; pantothenic acid; phosphatidylcholine; ph Antimalarial; Choline; Glucose; Malaria; Pantothenate

Citation

Source

Current Drug Targets

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31